pH-sensitive (responsive) gels are a subgroup of
Composition of polymeric solutions (in grams).
C940-0.10 | 0.100 | - | - | - | 99.900 | - |
C940-0.70 | 0.700 | - | - | - | 99.300 | - |
C940-1.30 | 1.300 | - | - | - | 98.700 | - |
PCP-0.200 | - | 0.200 | - | - | 99.800 | - |
PCP-0.225 | - | 0.225 | - | - | 99.775 | - |
PCP-0.250 | - | 0.250 | - | - | 99.750 | - |
PCP-0.300 | - | 0.300 | - | - | 99.700 | - |
PCP-0.400 | - | 0.400 | - | - | 99.600 | - |
PCP-0.600 | - | 0.600 | - | - | 99.400 | - |
PCP-1.000 | - | 1.000 | - | - | 99.000 | - |
CHL-3000 | - | - | 3.000 | - | - | 97.000 |
CHL-3.50. | - | - | 3.500 | - | - | 96.500 |
CHM-200. | - | - | - | 2.000 | - | 98.000 |
CHM-2.50 | - | - | - | 2.500 | - | 97.500 |
CHM-30.0 | - | - | - | 3.000 | - | 97.000 |
Process parameters of preparation for individual polymers.
Carbomer | 300 | 330 | 30 |
Polycarbophil | 300 | 350 | 45 |
Chitosan | 500 | 700 | 45 |
The C940 and PCP formulations were tempered at 37 °C ± 1 °C in a tube. 1 M NaOH was added dropwise with continuous stirring. The pH was checked using a pH meter Seven Compact S220 (Mettler Toledo, USA). Gel formation was indicated by the lack of movement of meniscus on tilting the tube. It was not possible to determine the gelation pH of the CH samples in this way because a gel-like precipitate was formed after the addition of NaOH, which could not be homogenized. Therefore, the following procedure was chosen. Five hundred microliters of the CH sample colored with MB (1 drop/1 g of sample) were added to the buffer with a pH range of 3–14 tempered at 37 °C ± 1 °C, which was followed by vortexing (VELP Scientifica, IT) for 10 s at 800 rpm. The presence of the gel was observed immediately after the addition of sol. The gelation pH was evaluated as the pH of the buffer with the lowest pH at which the gel formed and remained visible even after vortexing. Samples were evaluated in triplicate.
Appearance of polymeric solutions and gels, pH of polymeric solutions, and pH of the gelation.
C940-0.10 | ++ | +++ | 3.57 ± 0.05 | 6.74 ± 0.47 |
C940-0.70 | ++ | +++ | 2.93 ± 0.10 | 3.01 ± 0.14 |
C940-1.30 | ++ | +++ | 2.66 ± 0.03 | 2.81 ± 0.02 |
PCP-0.200 | + | − | 3.68 ± 0.02 | − |
PCP-0.225 | + | +++ | 3.59 ± 0.05 | 6.61 ± 0.21 |
PCP-0.250 | + | +++ | 3.56 ± 0.03 | 6.02 ± 0.06 |
PCP-0.300 | + | +++ | 3.39 ± 0.03 | 5.36 ± 0.30 |
PCP-0.400 | + | +++ | 3.35 ± 0.04 | 4.19 ± 0.33 |
PCP-0.600 | + | ++ | 3.26 ± 0.04 | 4.03 ± 0.08 |
PCP-1.000 | + | + | 3.32 ± 0.24 | 3.36 ± 0.37 |
CHL-3000 | + | np | 4.62 ± 0.09 | 7.00 ± 0.00 |
CHL-3.50. | + | np | 5.05 ± 0.02 | 6.50 ± 0.00 |
CHM-200. | ++ | np | 4.33 ± 0.02 | 9.00 ± 0.00 |
CHM-2.50 | + | np | 4.52 ± 0.01 | 6.00 ± 0.00 |
CHM-30.0 | + | np | 4.85 ± 0.01 | 6.00 ± 0.00 |
The prepared sols showed a transparent to turbid appearance (Table 3). In this state, the polymers are coiled and form clumps that block the passage of light. By increasing the pH, the system turns into a gel and the polymers expand (Gupta et al., 2019). There are enough gaps between the polymer fibers that are filled with solvent and light passes more easily through the system arranged in this way. Therefore, most of the gels had a glassy appearance, except for PCP-1, where the gel was turbid. With PCP-0.2, we did not notice the formation of a gel, and with the CH formulations, gel-like clusters were formed, the appearance of which could not be determined.
Since C940 and PCP are polyacids (polyanions), with increasing concentration of polymer solutions, the pH decreased slightly (Table 3): for C940 from 3.57 ± 0.05 (C940-0.1) to 2.66 ± 0.03 (C940-1.3) and for PCP from 3.68 ± 0.02 (PCP-0.2) to 3.32 ± 0.24 (PCP-1). The higher the concentration of anionic polymers, the lower was the pH needed to form a gel: 2.81 ± 0.02 (C940-1.3), 3.36 ± 0.37 (PCP-1). On the contrary, the lower the concentration, the higher was the pH needed to form a gel: 6.74 ± 0.47 (C940-0.1), 6.61 ± 0.21 (PCP-0.225).
A higher concentration of polymer increases the viscosity and mucoadhesive strength of formulations (Singh et al., 2018). The low pH of 1% acetic acid (2.62 ± 0.01) was gradually increased by adding CH (Table 3), since CH is a polybase. Fig. 1 shows the change in the consistency of polymer solutions from liquid to gel form when the gelation pH is reached. At the same time, the difference in the appearance of sols and gels can be seen.
For convenient application of
For dissolution evaluation, we chose formulations that were injectable or the most liquid and had a gelation pH close to the pH of the oral cavity. The formulations C940-0.1, PCP-0.225, and CHM-2.5 were selected for dissolution.
Figure 1.
Appearance of formulation C940-0.1 (a) solution, (b) gel, PCP-0.225 (c) solution, (d) gel, CHM-2.5 (e) solution.

Injectability of polymeric solutions.
C940-0.10 | + | + | + | + |
C940-0.70 | − | − | − | − |
C940-1.30 | − | − | − | − |
PCP-0.200 | + | + | + | + |
PCP-0.225 | + | + | + | + |
PCP-0.250 | + | + | + | + |
PCP-0.300 | + | + | + | + |
PCP-0.400 | + | + | + | + |
PCP-0.600 | + | + | + | + |
PCP-1.000 | + | + | + | + |
CHL-3000 | − | − | − | − |
CHL-3.50. | − | − | − | − |
CHM-200. | − | − | − | − |
CHM-2.50 | − | − | − | − |
CHM-30.0 | − | − | − | − |
Calculated adjusted coefficient of determination (R2adj) of different mathematical models, fitted to released data in whole dissolution time (0–60 min).
C940-0.10 | 0.741 ± 0.046 | 0.975 ± 0.003 | 0.999 ± 0.001 |
PCP-0.225 | 0.637 ± 0.077 | 0.993 ± 0.002 | 0.990 ± 0.003 |
CHM-2.50 | 0.792 ± 0.032 | 0.956 ± 0.008 | 0.969 ± 0.004 |
We monitored the amount of MB released by dissolution in phosphate buffer of pH 6.8 for 60 min. According to the adjusted coefficient of determination (
Figure 2.
Dissolution profiles and Korsmeyer-Peppas fitting lines of formulations C940-0.1 (○, – • –), PCP-0.225 (▲, ‒‒‒) and CHM-2.5 (□, - - -).

Dissolution parameters of the Korsmeyer–Peppas model and released amount of the drug after 60 min dissolution.
C940-0.10 | 22.98 ± 4.95 | 0.31 ± 0.03 | 2.72 ± 0.21 | 16.54 ± 05.37 | 77.04 ± 5.94 |
PCP-0.225 | 19.70 ± 2.86 | 0.24 ± 0.04 | 4.04 ± 0.27 | 61.01 ± 20.48 | 48.85 ± 5.74 |
CHM-2.50 | 16.52 ± 3.42 | 0.39 ± 0.04 | 1.45 ± 0.61 | 19.29 ± 04.88 | 77.35 ± 4.98 |
In conclusion, we have prepared colloidal solutions with various concentrations of pH-sensitive polymers to determine the basic properties as a preliminary study. PCP-0.225 showed the best properties according to injectability, pH gelation, and prolonged release from all prepared compositions and could be used as a dosage form for oromucosal application.
Figure 1.

Figure 2.

Composition of polymeric solutions (in grams).
C940-0.10 | 0.100 | - | - | - | 99.900 | - |
C940-0.70 | 0.700 | - | - | - | 99.300 | - |
C940-1.30 | 1.300 | - | - | - | 98.700 | - |
PCP-0.200 | - | 0.200 | - | - | 99.800 | - |
PCP-0.225 | - | 0.225 | - | - | 99.775 | - |
PCP-0.250 | - | 0.250 | - | - | 99.750 | - |
PCP-0.300 | - | 0.300 | - | - | 99.700 | - |
PCP-0.400 | - | 0.400 | - | - | 99.600 | - |
PCP-0.600 | - | 0.600 | - | - | 99.400 | - |
PCP-1.000 | - | 1.000 | - | - | 99.000 | - |
CHL-3000 | - | - | 3.000 | - | - | 97.000 |
CHL-3.50. | - | - | 3.500 | - | - | 96.500 |
CHM-200. | - | - | - | 2.000 | - | 98.000 |
CHM-2.50 | - | - | - | 2.500 | - | 97.500 |
CHM-30.0 | - | - | - | 3.000 | - | 97.000 |
Injectability of polymeric solutions.
C940-0.10 | + | + | + | + |
C940-0.70 | − | − | − | − |
C940-1.30 | − | − | − | − |
PCP-0.200 | + | + | + | + |
PCP-0.225 | + | + | + | + |
PCP-0.250 | + | + | + | + |
PCP-0.300 | + | + | + | + |
PCP-0.400 | + | + | + | + |
PCP-0.600 | + | + | + | + |
PCP-1.000 | + | + | + | + |
CHL-3000 | − | − | − | − |
CHL-3.50. | − | − | − | − |
CHM-200. | − | − | − | − |
CHM-2.50 | − | − | − | − |
CHM-30.0 | − | − | − | − |
Appearance of polymeric solutions and gels, pH of polymeric solutions, and pH of the gelation.
C940-0.10 | ++ | +++ | 3.57 ± 0.05 | 6.74 ± 0.47 |
C940-0.70 | ++ | +++ | 2.93 ± 0.10 | 3.01 ± 0.14 |
C940-1.30 | ++ | +++ | 2.66 ± 0.03 | 2.81 ± 0.02 |
PCP-0.200 | + | − | 3.68 ± 0.02 | − |
PCP-0.225 | + | +++ | 3.59 ± 0.05 | 6.61 ± 0.21 |
PCP-0.250 | + | +++ | 3.56 ± 0.03 | 6.02 ± 0.06 |
PCP-0.300 | + | +++ | 3.39 ± 0.03 | 5.36 ± 0.30 |
PCP-0.400 | + | +++ | 3.35 ± 0.04 | 4.19 ± 0.33 |
PCP-0.600 | + | ++ | 3.26 ± 0.04 | 4.03 ± 0.08 |
PCP-1.000 | + | + | 3.32 ± 0.24 | 3.36 ± 0.37 |
CHL-3000 | + | np | 4.62 ± 0.09 | 7.00 ± 0.00 |
CHL-3.50. | + | np | 5.05 ± 0.02 | 6.50 ± 0.00 |
CHM-200. | ++ | np | 4.33 ± 0.02 | 9.00 ± 0.00 |
CHM-2.50 | + | np | 4.52 ± 0.01 | 6.00 ± 0.00 |
CHM-30.0 | + | np | 4.85 ± 0.01 | 6.00 ± 0.00 |
Dissolution parameters of the Korsmeyer–Peppas model and released amount of the drug after 60 min dissolution.
C940-0.10 | 22.98 ± 4.95 | 0.31 ± 0.03 | 2.72 ± 0.21 | 16.54 ± 05.37 | 77.04 ± 5.94 |
PCP-0.225 | 19.70 ± 2.86 | 0.24 ± 0.04 | 4.04 ± 0.27 | 61.01 ± 20.48 | 48.85 ± 5.74 |
CHM-2.50 | 16.52 ± 3.42 | 0.39 ± 0.04 | 1.45 ± 0.61 | 19.29 ± 04.88 | 77.35 ± 4.98 |
Calculated adjusted coefficient of determination (R2adj) of different mathematical models, fitted to released data in whole dissolution time (0–60 min).
C940-0.10 | 0.741 ± 0.046 | 0.975 ± 0.003 | 0.999 ± 0.001 |
PCP-0.225 | 0.637 ± 0.077 | 0.993 ± 0.002 | 0.990 ± 0.003 |
CHM-2.50 | 0.792 ± 0.032 | 0.956 ± 0.008 | 0.969 ± 0.004 |
Process parameters of preparation for individual polymers.
Carbomer | 300 | 330 | 30 |
Polycarbophil | 300 | 350 | 45 |
Chitosan | 500 | 700 | 45 |
Retraction Note Technological Processing of Dried Powdered Rosehips to Tablets Through Wet Granulation A Multiple Unit Abuse-deterrent Dosage Form Based on Sodium Alginate Optimization of the Microscopic Method of Observing of the Oleogel Structure Formulation Options for Mucoadhesive Dosage Forms for Use in the Oral Cavity Microemulsions as the Potential Delivery System for Nimodipine Synthesis, antioxidant activity, and HPLC enantioseparation of aryloxyaminopropanols derived from naphthalen-2-ol Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients Book of Abstracts 39th Technology Days 7th and 8th September 2023 Pilot Formulation Study of Ph-sensitive Gels Experimental evaluation of the nonselective and selective TMEM16 family calcium-activated chloride channel blockers in the airways Spheroids as 3D Cell Models for Testing of Drugs Glyceryl Laurate Tablets: Effect of the Excipients and Granule Size on the Tablet Quality Evaluation of Properties of Dexamethasone Eye Drops